Live Breaking News & Updates on Alimera Sciences Trading

Stay updated with breaking news from Alimera sciences trading. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

StockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to Hold

StockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to Hold
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Alimera Sciences Company Profile , Capital Management , Alimera Sciences , Stonepine Capital Management , Alimera Sciences Trading , Alimera Sciences Inc , News Ratings For Alimera Sciences Daily , Maxim Group , Worth Venture Partners , Free Report , Get Free Report , Venture Partners , Fifth Lane Capital , Operating Cost , Alimera Sciences Daily ,

Alimera Sciences (NASDAQ:ALIM) Upgraded to Buy at StockNews.com

Alimera Sciences (NASDAQ:ALIM – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Monday. Separately, Maxim Group initiated coverage on shares of Alimera Sciences in a research report on Monday, March 25th. They set a “buy” rating and a $10.00 price target […] ....

United States , News Ratings For Alimera Sciences Daily , Capital Management , Worth Venture Partners , Alimera Sciences Inc , Stonepine Capital Management , Maxim Group , Institutional Trading Of Alimera Sciences , Alimera Sciences Trading , Alimera Sciences Company Profile , Alimera Sciences , Get Free Report , Operating Cost , Alimera Sciences Daily , Nasdaq Alim , Stocknews Com ,

Alimera Sciences (NASDAQ:ALIM) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $5.00 price objective on shares of Alimera Sciences in a report on Monday, […] ....

United States , Alimera Sciences Trading , Alimera Sciences , Capital Management , Alimera Sciences Company Profile , Stonepine Capital Management , Institutional Trading Of Alimera Sciences , News Ratings For Alimera Sciences Daily , Susquehanna International Group , Alimera Sciences Inc , Worth Venture Partners , Free Report , Get Free Report , Capital Investment Management , Venture Partners , Operating Cost , Alimera Sciences Daily , Nasdaq Alim , Initiated Coverage , Stocknews Com ,

Alimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $5.00 target price on shares of Alimera Sciences in a report on Monday, August 14th. […] ....

United States , Tower Research Capital , Renaissance Technologies , Geode Capital Management , Osaic Holdings Inc , Millennium Management , Alimera Sciences Trading , News Ratings For Alimera Sciences Daily , Alimera Sciences , Alimera Sciences Company Profile , Alimera Sciences Inc , Free Report , Get Free Report , Research Capital , Capital Management , Operating Cost , Alimera Sciences Daily , Nasdaq Alim , Initiated Coverage , Stocknews Com ,